# Filing Detail

Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-17-007712
Filing Date
2017-12-18
Accepted
2017-12-18 07:09:08
Documents
7

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B5 | a2234065z424b5.htm | 424B5 | 630638
2 | G467069.JPG | g467069.jpg | GRAPHIC | 24994
3 | G819290.JPG | g819290.jpg | GRAPHIC | 55764
4 | G343675.JPG | g343675.jpg | GRAPHIC | 59298
5 | G72021.JPG | g72021.jpg | GRAPHIC | 61322
6 | G837899.JPG | g837899.jpg | GRAPHIC | 134109
7 | G715173.JPG | g715173.jpg | GRAPHIC | 128409
| Complete submission text file | 0001047469-17-007712.txt |  | 1271489

Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-206135 | Film No.: 171260306
SIC: 2834 Pharmaceutical Preparations